OR WAIT null SECS
© 2022 MJH Life Sciences and BioPharm International. All rights reserved.
© 2022 MJH Life Sciences™ and BioPharm International. All rights reserved.
The continuous, aseptic fill/finish process is finding use in vaccines and biologic drugs.
Lighthouse manufacturing techniques utilize technology and automation to streamline production.
Qualified algorithms enable validation of machine learning models.
May 03, 2022
An increasingly complex development pipeline and industry considerations, such as sustainability, are leading to a greater need for more efficient separation and purification in downstream processing.
May 02, 2022
Complex hurdles complicate the development of emerging therapies.
Plant-based manufacturing technology gains mainstream edge in biopharmaceutical production.
Workforce training is crucial for biopharmaceutical manufacturing.
May 01, 2022
Understanding both the challenges and solutions of aseptic manufacturing.
This article summarizes industry views on PAT in bioprocess-related applications and presents a vision for the biopharmaceutical industry to achieve Industry 4.0.
Applying modeling methods in preclinical studies can be a powerful tool for generating data and shortening development timelines.
April 28, 2022
Societal CDMO has been awarded a new manufacturing and packaging task order agreement by National Cancer Institute.
April 22, 2022
FDA has approved commercial production at Kite’s new CAR T-cell therapy manufacturing facility in Frederick, Maryland.
Catalent will invest $350 million into integrated biologics drug substance and drug product manufacturing at Bloomington, Indiana facility.